DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the company's ...

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

Fintel reports that on September 26, 2025, Baird maintained coverage of DexCom (NasdaqGS:DXCM) with a Outperform ...

Now through Sept. 19, people in the U.S. and Canada from 2 years and older living with all types of diabetes and prediabetes can apply for a once-in-a-lifetime opportunity to raise diabetes awareness ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...

Investing.com - Oppenheimer downgraded DexCom (NASDAQ:DXCM) stock rating from Outperform to Perform on Monday, citing multiple challenges facing the continuous glucose monitoring device maker.

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 3.3% in the afternoon session after company executives provided an optimistic outlook at the Wells Fargo Healthcare Conference on Wednesday ...

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...

Dexcom ( ($DXCM) ) has provided an announcement. On September 14, 2025, Dexcom announced that CEO and Chairman Kevin R. Sayer took a temporary ...

Investing.com - Piper Sandler has reiterated its Overweight rating and $100.00 price target on DexCom (NASDAQ:DXCM), following investor calls with Midwest diabetes clinicians this week. The diabetes ...

Dexcom, a San Diego biotech company known for its continuous glucose monitoring systems, is laying off a few hundred workers as it moves its operations and manufacturing from California to Arizona.

Next presentation this afternoon is from DexCom, a leader in developing and commercializing continuous glucose monitoring systems for people with diabetes and I'm sure in the future beyond diabetes.